blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1856045

EP1856045 - 1-ACETIC ACID-INDOLE DERIVATIVES WITH PGD2 ANTAGONIST ACTIVITY [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  16.07.2010
Database last updated on 25.09.2024
Most recent event   Tooltip16.07.2010No opposition filed within time limitpublished on 18.08.2010  [2010/33]
Applicant(s)For all designated states
Oxagen Limited
91 Milton Park, Abingdon
Oxfordshire OX14 4RY / GB
[2007/47]
Inventor(s)01 / ARMER, Richard, Edward
91 Milton Park
Abingdon, Oxfordshire OX14 4RY / GB
02 / BOYD, Edward, Andrew
Evotec OAI
151 Milton Park, Abingdon, Oxon OX14 4RY / GB
03 / HAY, Philip, Andrew
Evotec OAI
151 Milton Park, Abingdon, Oxon OX14 4RY / GB
 [2007/47]
Representative(s)Roberts, Alison Christine, et al
Kilburn & Strode LLP
20 red Lion Street
London WC1R 4PJ / GB
[N/P]
Former [2009/37]Roberts, Alison Christine, et al
Kilburn & Strode LLP 20 red Lion Street
London WC1R 4PJ / GB
Former [2007/47]Roberts, Alison Christine, et al
Kilburn & Strode, 20 Red Lion Street
London WC1R 4PJ / GB
Application number, filing date06726357.410.03.2006
[2007/47]
WO2006GB00851
Priority number, dateGB2005000504811.03.2005         Original published format: GB 0505048
[2007/47]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2006095183
Date:14.09.2006
Language:EN
[2006/37]
Type: A1 Application with search report 
No.:EP1856045
Date:21.11.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 14.09.2006 takes the place of the publication of the European patent application.
[2007/47]
Type: B1 Patent specification 
No.:EP1856045
Date:09.09.2009
Language:EN
[2009/37]
Search report(s)International search report - published on:EP14.09.2006
ClassificationIPC:C07D209/30, C07D209/42, A61K31/405, A61P11/00, A61P37/00
[2007/47]
CPC:
C07D403/06 (EP,KR,US); A61K31/404 (KR); A61P1/00 (EP);
A61P1/04 (EP); A61P11/00 (EP); A61P11/06 (EP);
A61P17/00 (EP); A61P17/06 (EP); A61P17/10 (EP);
A61P19/02 (EP); A61P25/00 (EP); A61P25/16 (EP);
A61P25/28 (EP); A61P27/14 (EP); A61P29/00 (EP);
A61P37/00 (EP); A61P37/06 (EP); A61P37/08 (EP);
A61P9/10 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/47]
Extension statesAL20.09.2007
BA20.09.2007
HR20.09.2007
MK20.09.2007
YU20.09.2007
TitleGerman:1-ESSIGSÄUREINDOLDERIVATE MIT PGD2-ANTAGONISTISCHER WIRKUNG[2007/47]
English:1-ACETIC ACID-INDOLE DERIVATIVES WITH PGD2 ANTAGONIST ACTIVITY[2007/47]
French:DERIVES D'INDOL-1-YL ACIDE ACETIQUE AYANT UNE ACTIVITE ANTAGONISTE DE PGD2[2009/13]
Former [2007/47]DERIVES D'INDOLE SUBSTITUE PAR L'ACIDE CETIQUE EN POSITION 1 AYANT UNE ACTIVITE D'ANTAGONISTE DE PGD2
Entry into regional phase20.09.2007National basic fee paid 
20.09.2007Designation fee(s) paid 
20.09.2007Examination fee paid 
Examination procedure20.09.2007Examination requested  [2007/47]
31.10.2008Despatch of a communication from the examining division (Time limit: M04)
12.12.2008Reply to a communication from the examining division
30.03.2009Communication of intention to grant the patent
20.07.2009Fee for grant paid
20.07.2009Fee for publishing/printing paid
Opposition(s)10.06.2010No opposition filed within time limit [2010/33]
Fees paidRenewal fee
12.06.2008Renewal fee patent year 03
13.03.2009Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
31.03.200803   M06   Fee paid on   12.06.2008
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO03101981  (ASTRAZENECA AB [SE], et al) [A] 1-16* claims 1,10 *;
 [Y]WO2004007451  (ASTRAZENECA AB [SE], et al) [Y] 1-16 * claims 1,9 *;
 [Y]EP1505061  (SHIONOGI & CO [JP]) [Y] 1-16 * claims 1,14 *;
 [Y]WO2005019171  (ASTRAZENECA AB [SE], et al) [Y] 1-16 * claims 1,10 *;
 [PY]WO2005044260  (OXAGEN LTD [GB], et al) [PY] 1-16 * claims 1,25 *;
 [PY]WO2005054232  (ASTRAZENECA AB [SE], et al) [PY] 1-16 * claims 1,11 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.